PRAX
Price
$42.44
Change
+$0.81 (+1.95%)
Updated
Jun 24, 12:53 PM (EDT)
Capitalization
862.42M
56 days until earnings call
XENE
Price
$32.10
Change
+$0.61 (+1.94%)
Updated
Jun 24, 01:24 PM (EDT)
Capitalization
2.46B
44 days until earnings call
Interact to see
Advertisement

PRAX vs XENE

Header iconPRAX vs XENE Comparison
Open Charts PRAX vs XENEBanner chart's image
Praxis Precision Medicines
Price$42.44
Change+$0.81 (+1.95%)
Volume$100
Capitalization862.42M
Xenon Pharmaceuticals
Price$32.10
Change+$0.61 (+1.94%)
Volume$100
Capitalization2.46B
PRAX vs XENE Comparison Chart in %
Loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRAX vs. XENE commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRAX is a Buy and XENE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (PRAX: $41.63 vs. XENE: $31.49)
Brand notoriety: PRAX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRAX: 68% vs. XENE: 75%
Market capitalization -- PRAX: $862.42M vs. XENE: $2.46B
PRAX [@Biotechnology] is valued at $862.42M. XENE’s [@Biotechnology] market capitalization is $2.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRAX’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • PRAX’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRAX’s TA Score shows that 3 TA indicator(s) are bullish while XENE’s TA Score has 3 bullish TA indicator(s).

  • PRAX’s TA Score: 3 bullish, 5 bearish.
  • XENE’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, XENE is a better buy in the short-term than PRAX.

Price Growth

PRAX (@Biotechnology) experienced а -4.98% price change this week, while XENE (@Biotechnology) price change was -1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +34.44%, and the average quarterly price growth was +16.31%.

Reported Earning Dates

PRAX is expected to report earnings on Aug 19, 2025.

XENE is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($2.46B) has a higher market cap than PRAX($862M). XENE YTD gains are higher at: -19.668 vs. PRAX (-45.907). PRAX has higher annual earnings (EBITDA): -232.71M vs. XENE (-290.36M). XENE has more cash in the bank: 550M vs. PRAX (328M). PRAX has less debt than XENE: PRAX (1.07M) vs XENE (8.68M). PRAX has higher revenues than XENE: PRAX (8.12M) vs XENE (7.5M).
PRAXXENEPRAX / XENE
Capitalization862M2.46B35%
EBITDA-232.71M-290.36M80%
Gain YTD-45.907-19.668233%
P/E RatioN/AN/A-
Revenue8.12M7.5M108%
Total Cash328M550M60%
Total Debt1.07M8.68M12%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRAXXENE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 8 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMCX7.610.08
+1.06%
Royce Micro-Cap Consult
SLVAX34.86N/A
N/A
Columbia Select Large Cap Value A
OTCHX29.57N/A
N/A
MFS Mid Cap Growth R3
BCSSX47.71N/A
N/A
Brown Capital Mgmt Small Co Instl
MMMMX39.32N/A
N/A
Victory Integrity Discovery Member

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-1.68%
CDXS - PRAX
49%
Loosely correlated
+3.06%
MNMD - PRAX
45%
Loosely correlated
-5.74%
DNLI - PRAX
45%
Loosely correlated
-1.94%
ABCL - PRAX
41%
Loosely correlated
-2.35%
XENE - PRAX
40%
Loosely correlated
-1.75%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with IDYA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
-1.75%
IDYA - XENE
56%
Loosely correlated
-1.15%
CRNX - XENE
54%
Loosely correlated
-0.83%
ATXS - XENE
53%
Loosely correlated
-4.27%
KYMR - XENE
50%
Loosely correlated
+0.92%
NRIX - XENE
49%
Loosely correlated
+4.26%
More